Surgical & Medical Instruments & Apparatus
Standard Industrial Classification: SIC 3841
Industry Insider Sentiment Analysis
The Surgical & Medical Instruments & Apparatus sector (SIC 3841) acts as a critical barometer for broader economic health. Our real-time monitoring reveals total transactions. Monitoring "cluster buying" is one of the most reliable leading indicators for future sector performance. By analyzing aggregate data across this specific Standard Industrial Classification, investors can filter out individual company volatility and identify high-conviction trends. When multiple directors and officers within the same industry move capital simultaneously, it often signals an upcoming sector-wide revaluation or a fundamental shift in supply chain dynamics that has yet to be recognized by the broader public market.
| Filing Date | Trade Date | Ticker | Company | Reporting Person | Relationship | Type | Price | Qty | Total, $ | Owned After |
|---|---|---|---|---|---|---|---|---|---|---|
| 2017-06-15 01:11 | 2017-06-12 | TCMD | TACTILE SYSTEMS TECHNOLOGY INC | BURKE WILLIAM W | Director | SELL | $25.25 | 1,500 | $37,875 | 8,306 |
| 2017-06-14 23:31 | 2017-06-13 | TCMD | TACTILE SYSTEMS TECHNOLOGY INC | Galen Partners V LP | 10% owner | SELL | $25.00 | 295,455 | $7,386,375 | 3,985,233 |
| 2017-06-14 01:35 | 2017-06-09 | NVCR | NovoCure Ltd | Danziger Asaf | Director, Officer | SELL | $15.13 | 180,601 | $2,731,915 | 1,158,196 |
| 2017-06-14 01:19 | 2017-06-09 | NVCR | NovoCure Ltd | Kirson Eilon D. | Officer | SELL | $15.03 | 20,956 | $315,053 | 313,127 |
| 2017-06-13 23:19 | 2017-06-09 | NEPH | NEPHROS INC | Evans Daron | Director, Officer | BUY | $0.26 | 21,461 | $5,580 | 49,166 |
| 2017-06-14 02:20 | 2017-06-09 | CMXC | Stimcell Energetics Inc. | JEFFS RICHARD | 10% owner | BUY | $0.18 | 50,000 | $9,000 | 2,512,266 |
| 2017-06-14 01:18 | 2017-06-09 | CTSO | Cytosorbents Corp | Mortensen Eric R. | Officer | BUY | $4.04 | 2,500 | $10,100 | 2,500 |
| 2017-06-14 00:27 | 2017-06-12 | DXCM | DEXCOM INC | Balo Andrew K | Officer | SELL | $69.06 | 3,200 | $220,989 | 106,433 |
| 2017-06-14 00:26 | 2017-06-12 | DXCM | DEXCOM INC | SAYER KEVIN R | Director, Officer | SELL | $69.07 | 6,000 | $414,411 | 332,680 |
| 2017-06-12 23:10 | 2017-06-09 | BSX | BOSTON SCIENTIFIC CORP | Pierce David A | Officer | OPT+S | $28.00 | 13,562 | $379,736 | 24,201 |
| 2017-06-13 01:51 | 2017-06-09 | CTSO | Cytosorbents Corp | BATOR MICHAEL G. | Director | BUY | $4.12 | 1,500 | $6,180 | 70,500 |
| 2017-06-12 16:58 | 2017-06-07 | TCMD | TACTILE SYSTEMS TECHNOLOGY INC | Folkes Robert J. | Officer | SELL | $25.00 | 1,500 | $37,500 | 131,337 |
| 2017-06-10 02:06 | 2017-06-07 | IRTC | iRhythm Holdings, Inc. | SYNERGY LIFE SCIENCE PARTNERS L P | 10% owner | SELL | $37.43 | 350,000 | $13,102,180 | 2,034,524 |
| 2017-06-10 00:29 | 2017-06-07 | INFU | InfuSystem Holdings, Inc | Meridian OHC Partners, LP | Director, 10% owner | BUY | $1.55 | 10,109 | $15,664 | 2,681,619 |
| 2017-06-08 23:15 | 2017-06-06 | TTOO | T2 Biosystems, Inc. | Spadoro Joanne | Officer | BUY | $3.50 | 5,000 | $17,500 | 5,589 |
| 2017-06-08 23:15 | 2017-06-06 | TTOO | T2 Biosystems, Inc. | Dhanda Rahul | Officer | BUY | $3.50 | 1,000 | $3,500 | 5,667 |
| 2017-06-08 23:15 | 2017-06-06 | TTOO | T2 Biosystems, Inc. | Gibbs Michael Terrence | Officer | BUY | $3.51 | 1,000 | $3,510 | 10,431 |
| 2017-06-09 00:37 | 2017-06-06 | IRTC | iRhythm Holdings, Inc. | Lathi Vijay K | Director | SELL | $37.59 | 430,624 | $16,185,477 | 665,965 |
| 2017-06-08 23:15 | 2017-06-06 | TTOO | T2 Biosystems, Inc. | Elsbree David B | Director | BUY | $3.50 | 10,000 | $35,000 | 50,000 |
| 2017-06-09 00:16 | 2017-06-07 | TFX | TELEFLEX INC | RANDLE STUART A | Director | OPT+S | $205.67 | 2,500 | $514,174 | 5,032 |
| 2017-06-09 01:38 | 2017-06-08 | CTSO | Cytosorbents Corp | Capponi Vincent | Officer | BUY | $4.00 | 2,500 | $10,000 | 275,062 |
| 2017-06-09 01:38 | 2017-06-08 | CTSO | Cytosorbents Corp | Chan Phillip P. | Director, Officer | BUY | $4.00 | 3,700 | $14,800 | 399,907 |
| 2017-06-09 01:37 | 2017-06-08 | CTSO | Cytosorbents Corp | Jones Edward Raymond | Director | BUY | $3.99 | 2,500 | $9,987 | 68,500 |
| 2017-06-08 23:15 | 2017-06-06 | TTOO | T2 Biosystems, Inc. | DEPTULA-HICKS DARLENE M | Officer | BUY | $3.58 | 4,000 | $14,320 | 4,000 |
| 2017-06-08 02:22 | 2017-06-05 | TCMD | TACTILE SYSTEMS TECHNOLOGY INC | Anderson Mary E. | Officer | OPT+S | $26.52 | 13,013 | $345,109 | 59,555 |
| 2017-06-08 02:21 | 2017-06-05 | TCMD | TACTILE SYSTEMS TECHNOLOGY INC | Rishe Bryan | Officer | SELL | $26.45 | 1,500 | $39,670 | 113,807 |
| 2017-06-07 00:17 | 2017-06-05 | NVCR | NovoCure Ltd | Palti Yoram | Director, Officer | SELL | $13.82 | 3,825 | $52,842 | 0 |
| 2017-06-07 01:50 | 2017-06-05 | SYK | STRYKER CORP | Floyd David | Officer | OPT+S | $144.70 | 7,381 | $1,068,031 | 27,873 |
| 2017-06-06 23:05 | 2017-06-05 | GMED | GLOBUS MEDICAL INC | Williams Anthony L | Officer | OPT+S | $31.94 | 16,153 | $515,943 | 0 |
| 2017-06-06 21:11 | 2017-06-05 | RMD | RESMED INC | PENDARVIS DAVID | Officer | OPT+S | $72.62 | 6,365 | $462,226 | 78,112 |
| 2017-06-06 21:44 | 2017-06-05 | RMD | RESMED INC | FARRELL PETER C | Director | OPT+S | $72.65 | 20,000 | $1,452,960 | 301,557 |
| 2017-06-06 23:10 | 2017-06-05 | CTSO | Cytosorbents Corp | Chan Phillip P. | Director, Officer | BUY | $4.00 | 6,300 | $25,200 | 396,207 |
| 2017-06-05 23:19 | 2017-06-01 | NVCR | NovoCure Ltd | Palti Yoram | Director, Officer | SELL | $13.27 | 8,000 | $106,140 | 3,825 |
| 2017-06-05 23:17 | 2017-06-02 | BSX | BOSTON SCIENTIFIC CORP | Pierce David A | Officer | OPT+S | $27.70 | 2,972 | $82,313 | 24,201 |
| 2017-06-05 20:12 | 2017-06-01 | RMD | RESMED INC | Sandercock Brett | Officer | SELL | $71.02 | 1,250 | $88,775 | 61,758 |
| 2017-06-06 00:05 | 2017-06-01 | TCMD | TACTILE SYSTEMS TECHNOLOGY INC | Anderson Mary E. | Officer | OPT+S | $25.95 | 40,242 | $1,044,372 | 59,555 |
| 2017-05-31 00:08 | 2017-05-25 | NVCR | NovoCure Ltd | Palti Yoram | Director, Officer | SELL | $12.88 | 8,000 | $103,004 | 19,825 |
| 2017-05-30 23:15 | 2017-05-30 | BSX | BOSTON SCIENTIFIC CORP | Phalen Michael P. | Officer | OPT+S | $27.25 | 15,500 | $422,369 | 101,919 |
| 2017-05-30 23:58 | 2017-05-25 | MDXG | MIMEDX GROUP, INC. | Taylor William Charles | Director, Officer | SELL | $13.74 | 26,571 | $364,963 | 533,612 |
| 2017-05-31 04:16 | 2017-05-17 | REPR | KORU Medical Systems, Inc. | Anderson David W | Director | SELL | $0.40 | 23,315 | $9,326 | 7,353 |
| 2017-05-30 23:24 | 2017-05-26 | MRIC | ClearPoint Neuro, Inc. | Jenkins Kimble L. | Director | BUY | $0.00 | 7,500 | $0 | 34,638 |
| 2017-05-30 23:22 | 2017-05-26 | MRIC | ClearPoint Neuro, Inc. | Grillo Francis P | Director, Officer | BUY | $0.00 | 12,500 | $0 | 44,588 |
| 2017-05-30 23:56 | 2017-05-30 | OSUR | ORASURE TECHNOLOGIES INC | Patrick Charles W | Director | SELL | $15.15 | 6,666 | $100,990 | 52,104 |
| 2017-05-30 23:55 | 2017-05-26 | OSUR | ORASURE TECHNOLOGIES INC | LANCASTER RONNY B | Director | OPT+S | $14.79 | 89,684 | $1,326,373 | 6,295 |
| 2017-05-30 23:12 | 2017-05-25 | TCMD | TACTILE SYSTEMS TECHNOLOGY INC | Anderson Mary E. | Officer | OPT+S | $23.08 | 7,768 | $179,254 | 59,555 |
| 2017-05-27 00:34 | 2017-05-24 | INFU | InfuSystem Holdings, Inc | Meridian OHC Partners, LP | Director, 10% owner | BUY | $1.55 | 6,105 | $9,463 | 2,666,410 |
| 2017-05-26 23:24 | 2017-05-25 | IART | INTEGRA LIFESCIENCES HOLDINGS CORP | ESSIG STUART | Director | OPT+S | $49.90 | 135,000 | $6,736,500 | 2,077,475 |
| 2017-05-26 23:50 | 2017-05-24 | MMSI | MERIT MEDICAL SYSTEMS INC | EDELMAN RICHARD W | Director | OPT+S | $34.46 | 16,000 | $551,315 | 15,000 |
| 2017-05-27 00:38 | 2017-05-24 | LMAT | LEMAITRE VASCULAR INC | Kamke Trent G | Officer | OPT+S | $30.28 | 15,780 | $477,822 | 15,561 |
| 2017-05-26 17:25 | 2017-05-25 | BDX | BECTON DICKINSON & CO | SHERMAN JEFFREY S | Officer | OPT+S | $185.98 | 28,765 | $5,349,715 | 22,094 |
Sector-Wide Insider Alpha
Analyzing insider movements across the Surgical & Medical Instruments & Apparatus sector provides a macro-view of executive conviction. When multiple leaders in different companies within the same SIC code (3841) simultaneously buy shares, it often indicates an industry-wide undervaluation or a positive shift in market cycles.
SEC Filings in Surgical & Medical Instruments & Apparatus
Every transaction in the Surgical & Medical Instruments & Apparatus industry is reported via Form 4 disclosures. By filtering these filings by industry, investors can detect institutional-scale sentiment shifts before they are reflected in broader market indices, following the capital flow of those with intimate industry knowledge.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.